Novel psychoactive substances: the rising wave of 'legal highs'. Gilani F. Br J Gen Pract. 2016 Jan;66(642):8-9. doi: 10.3399/bjgp16X683053. No abstract available. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684028/

BMJ. Novel psychoactive substances (NPS):  Infografic Novel psychoactive substances (NPS), sometimes incorrectly called “legal highs,” include a multitude of substances, with many different effects. This infographic classi es NPS i…

The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol. Khaled SM, Hughes E, Bressington D, Zolezzi M, Radwan A, Badnapurkar A, Gray R. Syst Rev. 2016 Nov 21;5(1):195. https://systemati…

Synthetische Drogen – wichtige und neue Substanzen im Überblick Synthetic Drugs – An Overview of Important and Newly Emerging Substances F. Betzler, A. Heinz, S. Köhler Fortschr Neurol Psychiatr 2016; 84(11): 690-698 DOI: 1…

The rapid evolution of the European market for new psychoactive substances (NPS) has challenged national authorities to find suitable and efficient responses to the public health and judicial problems caused by these substances. The legal issues sur…

NPS and the methadone queue: Spillages of space and time. Alexandrescu L. Int J Drug Policy. 2016 Oct 24. pii: S0955-3959(16)30304-8. doi: 10.1016/j.drugpo.2016.09.009. Abstract https://www.ncbi.nlm.nih.gov/pubmed/27789102